» Articles » PMID: 18538410

Use of Non-mammalian Alternative Models for Neurotoxicological Study

Overview
Journal Neurotoxicology
Date 2008 Jun 10
PMID 18538410
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

The field of neurotoxicology needs to satisfy two opposing demands: the testing of a growing list of chemicals, and resource limitations and ethical concerns associated with testing using traditional mammalian species. National and international government agencies have defined a need to reduce, refine or replace mammalian species in toxicological testing with alternative testing methods and non-mammalian models. Toxicological assays using alternative animal models may relieve some of this pressure by allowing testing of more compounds while reducing expense and using fewer mammals. Recent advances in genetic technologies and the strong conservation between human and non-mammalian genomes allow for the dissection of the molecular pathways involved in neurotoxicological responses and neurological diseases using genetically tractable organisms. In this review, applications of four non-mammalian species, zebrafish, cockroach, Drosophila, and Caenorhabditis elegans, in the investigation of neurotoxicology and neurological diseases are presented.

Citing Articles

Assessment of developmental neurotoxicology-associated alterations in neuronal architecture and function using .

Huayta J, Seay S, Laster J, Rivera Jr N, Rivera N, Joyce A bioRxiv. 2025; .

PMID: 39868199 PMC: 11761668. DOI: 10.1101/2025.01.11.632560.


Current methodologies available to evaluate the virulence potential among clonal complexes.

Sousa M, Magalhaes R, Ferreira V, Teixeira P Front Microbiol. 2024; 15:1425437.

PMID: 39493856 PMC: 11528214. DOI: 10.3389/fmicb.2024.1425437.


Laboratory and physiological aspects of substitute metazoan models for in vivo pharmacotoxicological analysis.

Ferreira P, Ramos C, Filho J, Conceicao M, Almeida M, do Nascimento Rodrigues D Naunyn Schmiedebergs Arch Pharmacol. 2024; 398(2):1315-1339.

PMID: 39298017 DOI: 10.1007/s00210-024-03437-5.


as an emerging model in neurotoxicology.

Adedara I, Mohammed K, Canzian J, Rosemberg D, Aschner M, Farombi E Adv Neurotoxicol. 2023; 9:181-196.

PMID: 37389201 PMC: 10310038. DOI: 10.1016/bs.ant.2023.01.004.


Neurotoxicology of metals and metallic nanoparticles in .

Agarrayua D, Silva A, Saraiva N, Soares A, Aschner M, Avila D Adv Neurotoxicol. 2023; 9:107-148.

PMID: 37384197 PMC: 10306323. DOI: 10.1016/bs.ant.2023.03.001.


References
1.
Burkhart C . Ivermectin: an assessment of its pharmacology, microbiology and safety. Vet Hum Toxicol. 2000; 42(1):30-5. View

2.
Hong C, Peterson Q, Hong J, Peterson R . Artery/vein specification is governed by opposing phosphatidylinositol-3 kinase and MAP kinase/ERK signaling. Curr Biol. 2006; 16(13):1366-72. PMC: 1930149. DOI: 10.1016/j.cub.2006.05.046. View

3.
Caboni P, Sammelson R, Casida J . Phenylpyrazole insecticide photochemistry, metabolism, and GABAergic action: ethiprole compared with fipronil. J Agric Food Chem. 2003; 51(24):7055-61. DOI: 10.1021/jf030439l. View

4.
Thackeray J, Ganetzky B . Conserved alternative splicing patterns and splicing signals in the Drosophila sodium channel gene para. Genetics. 1995; 141(1):203-14. PMC: 1206718. DOI: 10.1093/genetics/141.1.203. View

5.
Song W, Liu Z, Tan J, Nomura Y, Dong K . RNA editing generates tissue-specific sodium channels with distinct gating properties. J Biol Chem. 2004; 279(31):32554-61. PMC: 3066004. DOI: 10.1074/jbc.M402392200. View